SODEXO LIMITED
Company number 00842846 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment — SODEXO LIMITED
Company no. 00842846 · Head office activities (SIC 70100) · Wholly owned subsidiary of Sodexo Holdings Limited · Ultimate parent Sodexo S.A. (Euronext Paris)
1. Financial Health Score: B+
| Grade | Meaning |
|---|---|
| A | Robust — all vitals strong, low risk |
| B | Healthy — sound fundamentals, manageable weaknesses |
| C | Watchlist — early warning signs |
| D | Distressed — material solvency or earnings concerns |
| F | Critical — going concern risk |
Why B+: This is a fundamentally sound, well-capitalised, cash-generative business with a blue-chip parent, a Big Four audit opinion, and fully up-to-date filings. It is not a distressed patient. However, it carries two persistent low-grade symptoms — a thin operating margin (~4.5%) and a slow, steady erosion of net assets — that stop it reaching an A. Think of a patient with excellent circulation and no acute illness, but slightly declining bone density: not urgent, but worth treating.
2. Key Vital Signs
Figures below are drawn from the filed accounts. The financial data feed reports values in thousands; the audited narrative confirms turnover of £1,437m and net assets of £237.2m for FY2025, so figures are presented in £m.
| Vital Sign | FY2023 | FY2024 | FY2025 | Reading |
|---|---|---|---|---|
| Turnover (cardiac output) | 1,399.4 | 1,521.1 | 1,437.3 | −5.5% headline, +2.6% like-for-like |
| Operating profit | n/a | 65.8 | 64.6 | Marginally down |
| Operating margin (blood pressure) | n/a | 4.3% | 4.5% | Thin but stable/improving |
| Net assets (body mass) | 244.7 | 240.1 | 237.2 | −1.2% — slow erosion |
| Cash (oxygen saturation) | 61.6 | 56.7 | 218.9 | +286% — exceptional |
| Cash / turnover | 4.4% | 3.7% | 15.2% | Very strong |
| Cash / net assets | 25% | 24% | 92% | Balance sheet is almost entirely liquid |
| Days Sales Outstanding | — | 34.6 days | 32.7 days | Improving collections |
| Total assets | 1,219.8 | 1,206.5 | 1,221.3 | Stable |
| Share capital | — | — | 22.4 | Long-established equity base |
Derived indicators
- Return on net assets (operating): 64.6 / 237.2 = 27.2% — flattered by a deliberately thin equity base, not by exceptional profitability.
- Asset turnover: 1,437 / 1,221 = 1.18× — capital-efficient, asset-light service model.
- Equity ratio: 237.2 / 1,221.3 = 19.4% — the balance sheet is majority-funded by liabilities (payables, lease obligations and intra-group balances typical of a facilities-management business), not by shareholders' funds.
- Margin sensitivity: the cost base is roughly £1,373m. A 1% cost overrun would wipe out about 21% of operating profit. This is the single most important number in this assessment.
Compliance vitals (hygiene record)
- Status: Active, not in liquidation, administration or receivership.
- Accounts to 31 Aug 2025 filed 29 May 2026 — within the 9-month deadline, not overdue. Next due 31 May 2027.
- Confirmation statement current; next due 11 April 2027.
- Audited by KPMG LLP; full accounts prepared under FRS 101; Wates Corporate Governance Principles applied; s.172 stakeholder statement and strategic report present.
- No director disqualification records identified.
3. Diagnosis
What the numbers reveal
Healthy systems
- Excellent liquidity. Cash of £218.9m is a near-sixfold increase year on year and represents 92% of net assets. For a business of this type, that is a strong, well-oxygenated balance sheet with no visible short-term funding stress.
- Stable core profitability. A 4.5% operating margin on £1.44bn is normal for contract catering and facilities management — a high-volume, low-margin, labour-intensive model. The margin actually improved slightly (4.3% → 4.5%) despite revenue pressure, which tells you cost control held.
- Improving working capital. DSO fell from 34.6 to 32.7 days — roughly £7.5m of cash released through better client collections. Management is actively managing the receivables "circulation."
- Strong immune system. Wholly owned by Sodexo Holdings Limited, ultimately Sodexo S.A. — a group operating in 43 countries with over 425,000 employees. Parental support materially reduces the risk of acute financial failure, even though the entity's own equity cushion is modest.
- Clean governance and compliance record. No overdue filings, no insolvency events, audited accounts, and a documented risk framework (QSHE board, Information & Security Committee, Speak Up programme).
Symptoms of concern
- Equity is quietly shrinking. Net assets have fallen three years running: £244.7m → £240.1m → £237.2m. The company earned £64.6m at operating level yet lost £2.9m of net assets. That implies roughly £67m of outflows or other equity movements (distributions, financing costs, tax, actuarial or group restructuring effects) absorbing the profit. The filed narrative attributes part of the movement to a group legal-entity rationalisation and the transfer of the Live! segment. The symptom is real: profit is not accumulating as reserves.
- Top-line contraction, even if explainable. Headline turnover fell 5.5%. Management credibly explains this as the transfer of the Live! segment to Sodexo Live! UK Limited, with like-for-like growth of 2.6%. That's a fair explanation — but it means reported growth depends on a normalisation argument rather than the raw numbers.
- Razor-thin margin buffer. At 4.5%, the business has very little room for error. Food inflation, wage inflation, energy costs, or a single large contract loss could compress the margin materially. The UK employment-law changes flagged in the strategic report (labour costs, National Insurance) are a direct threat to this line.
- Balance-sheet dependency. With equity at only 19.4% of total assets, the company relies on trade payables, lease liabilities and intra-group funding. This is normal for the sector but leaves less shock absorption than the headline net assets suggest.
- Concentration and competitive exposure. Revenue is concentrated in a portfolio of large public and private sector contracts across Health & Care, Education and corporate segments. Contract retention is the lifeblood; a small number of losses would be felt quickly.
- Board and secretarial churn. One director resigned in April 2026 and the corporate secretary resigned in June 2026, with name shown to subscribers continuing as secretary. Not alarming, but worth watching for governance continuity.
Data caveat: the structured financial feed includes a "total liabilities" field of −£733,952k that is not reconcilable with total assets of £1,221,300k and net assets of £237,174k (which would imply liabilities nearer £984m). This assessment therefore relies on the audited narrative and the reconcilable figures (turnover, net assets, cash, operating profit) rather than that field.
Prognosis
Stable, low risk of acute distress, but not strengthening.
- Short term (12 months): Expect continued like-for-like revenue growth in the low single digits, an operating margin holding in the 4.0–4.8% band, and strong cash balances. The next accounts are due 31 May 2027 and there is no indication of a going-concern qualification. Risk of insolvency: low, given group backing.
- Medium term (2–3 years): The trajectory is the concern. If net assets keep drifting down ~1–2% a year while margins stay thin, the company becomes progressively more dependent on parent support and less able to absorb a shock. This is a "chronic, manageable condition" rather than an acute one — but chronic conditions compound if untreated.
- Key watch triggers: (i) a further fall in net assets for a fourth consecutive year; (ii) operating margin slipping below 4.0%; (iii) loss of a major contract or a rise in DSO above 35 days; (iv) any deterioration in the parent's own credit standing.
4. Recommendations
A. Protect the margin (the most valuable treatment) - Formalise inflation-recovery clauses across all contracts, with a standard indexation mechanism (CPI/RPI or basket-based) rather than ad-hoc negotiation. - Run a rolling labour-scheduling and productivity review — labour is the dominant cost, so a 1% efficiency gain is worth roughly £13–14m. - Consolidate procurement across food, consumables and energy to blunt input-cost volatility.
B. Rebuild the equity cushion - Review the distribution policy with the parent. Retaining a larger share of the £64.6m operating profit would reverse the net-asset drift and improve resilience. - Set a published internal target (e.g. net assets ≥ £250m, or equity ratio ≥ 22%) and report progress in the strategic report.
C. Keep the cash advantage - Push DSO below 30 days — each further day released is roughly £3.9m of cash. - Formalise an intra-group cash and covenant policy so that the strong entity-level cash position is genuinely available, not just visible. - Stress-test available liquidity against a scenario where group funding is withdrawn.
D. De-risk the balance sheet - Commission a clear reconciliation of the ~£984m of liabilities: trade payables, lease liabilities, provisions and intra-group balances. Understand what falls due within 12 months. - Confirm covenant headroom and any cross-default provisions to group debt.
E. Defend and diversify revenue - Invest in client retention programmes and Net Promoter tracking in Health & Care and Education, the segments driving growth. - Reduce dependence on any single client or sector; target adjacent public-sector markets with long contract terms.
F. Prepare for regulatory cost pressure - Model the financial impact of UK employment-law reform, National Insurance changes and minimum-wage uplifts before they land, and price them into contract renewals.
G. Strengthen governance continuity - Fill the corporate-secretary arrangements permanently and maintain a documented board-succession plan. - Continue Wates-principle reporting and keep the risk register live, particularly cyber and climate risk.
H. Institute a financial "health check" cadence - Track five numbers quarterly and escalate on breach: operating margin, DSO, net assets, cash headroom, and contract retention rate.